Acquired Hemophilia A in an African-American Male After Stem Cell Transplant for Sickle Cell Disease: Successful Treatment with Recombinant Porcine Factor VIII (OBI-1) and Tolerance Induction with Rituximab and Prednisone

被引：0

作者：

Lozier, Jay N. ^{[1
]}

Nghiem, Khanh ^{[1
]}

Lee, Martin ^{[2
]}

Hodsdon, Bonnie ^{[3
]}

Joe, Galen ^{[3
]}

Weitzel, R. Patrick ^{[4
]}

Tisdale, John F. ^{[5
]}

Hsieh, Matthew ^{[5
]}

机构：

[1] NIH, Dept Lab Med, Ctr Clin, Bethesda, MD 20892 USA

[2] Inspirat Biopharmaceut Inc, E Cambridge, MA USA

[3] NIH, Dept Rehabil Med, Ctr Clin, Bethesda, MD 20892 USA

[4] NHLBI, MCHB, NIH, Bethesda, MD 20892 USA

[5] NHLBI, Mol & Clin Hematol Branch, NIH, Bethesda, MD 20892 USA

来源：

BLOOD | 2012年 / 120卷 / 21期

关键词：

D O I：

10.1182/blood.V120.21.4631.4631

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4631

引用

页数：2

共 10 条

[1] Acquired haemophilia A after stem cell transplant for sickle cell disease: treatment with recombinant porcine factor VIII (OBI-1) and tolerance induction with rituximab/prednisone
Lozier, J. N.
Nghiem, K.
Lee, M.
Hodsdon, B.
Joe, g.
Weitzel, R. P.
Tisdale, J. F.
Hsieh, M.
HAEMOPHILIA, 2014, 20 (02) : E185 - E188
[2] Overview of the structure and manufacturing process for OBI-1, a recombinant porcine sequence, factor VIII for the treatment of acquired hemophilia A
Wojciechowski, Peter
Lai, Chee Kong
Xiong, Yi
Deer, Frank
HAEMOPHILIA, 2014, 20 : 181 - 181
[3] The Benefit of FVIII Measurement: Tailored Treatment with Obi-1, a Recombinant Porcine Sequence Factor VIII, in Subjects with Acquired Hemophilia a
Oladapo, Abiola
Epstein, Joshua
Novack, Aaron
Farin, Heinrich D.
BLOOD, 2014, 124 (21)
[4] Efficacy and safety of B-domain deleted recombinant porcine factor VIII (OBI-1) in the treatment of acquired hemophilia A: interim results
Greist, A.
Shapiro, A.
Kruse-Jarres, R.
St Louis, J.
Smith, H.
Gomperts, E.
HAEMOPHILIA, 2012, 18 : 1 - 1
[5] Recombinant B-Domain Deleted Porcine Factor VIII (OBI-1) Safety and Efficacy in the Treatment of Acquired Hemophilia A: Interim Results
St Louis, Jean
Kruse-Jarres, Rebecca
Greist, Anne
Shapiro, Amy D.
Smith, Hedy
Drebes, Anja B.
Lozier, Jay N.
Gomperts, Edward D.
BLOOD, 2012, 120 (21)
[6] The Effect of Inhibitory Antibodies on Acute Treatment of Bleeding Episodes with OBI-1, an Antihemophilic Factor VIII (recombinant), Porcine Sequence, in Patients with Acquired Hemophilia A
Farin, Heinrich D.
Novack, Aaron
Mo, Min
Bourgeois, Christelle
Horling, Frank M.
Ewenstein, Bruce M.
BLOOD, 2014, 124 (21)
[7] Recombinant porcine sequence factor VIII (OBI-1): Results from a prospective clinical study investigating the treatment of serious bleeds in patients with acquired hemophilia A
Kruse-Jarres, R.
St-Louis, J.
Greist, A.
Shapiro, A.
Smith, H.
Chowdary, P.
Drebes, A.
Gomperts, E.
Chapman, M.
Mo, M.
Novack, A.
Farin, H.
HAEMOPHILIA, 2014, 20 : 1 - 1
[8] TREATMENT OF SERIOUS BLEEDS IN A PROSPECTIVE CLINICAL TRIAL WITH A B-DOMAIN DELETED RECOMBINANT PORCINE SEQUENCE FACTOR VIII (OBI-1) IN PATIENTS WITH ACQUIRED HEMOPHILIA A
Kruse-Jarres, Rebecca
St-Louis, Jean
Greist, Anne
Shapiro, Amy
Smith, Hedy
Chowdary, Pratima
Drebes, Anja
Gomperts, Edward
Chapman, Miranda
Mo, Min
Novack, Aaron
Farin, Heinrich
AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (06) : E41 - E42
[9] Treatment Of Serious Bleeds With a B-Do Domain Deleted Recombinant Porcine Sequence Factor VIII (OBI-1) In Patients With Acquired Hemophilia A: A Prospective Clinical Trial
Kruse-Jarres, Rebecca
St Louis, Jean
Greist, Anne
Shapiro, Amy D.
Smith, Hedy
Chowdary, Pratima
Drebes, Anja B.
Gomperts, Edward D.
Chapman, Miranda
Mo, Min
Novack, Aaron
Farin, Heinrich D.
BLOOD, 2013, 122 (21)
[10] Acquired Haemophilia a after Allogeneic Stem Cell Transplant for Acute Myeloid Leukemia: Occurred during Cyclosporin a Used for Chronic Graft Versus Host Disease and Tolerance Induction with Rituximab
Fan, Zhiping
Liu, Qifa
Sun, Jing
BLOOD, 2014, 124 (21)

← 1 →